Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Short-term Investments (2025 - 2026)

Updated

Skye Bioscience (SKYE) reported Short-term Investments of $2 million for Q2 2026, down 91.9% from $24.75 million a year earlier and down 77.7% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Short-term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Skye Bioscience posted Short-term Investments of $19.85 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.96 million (Q1 2026), $19.85 million (Q4 2025) and $16.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 8.96 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 16.87 Mn
Jun 30, 2025 24.75 Mn
Mar 31, 2025 12.80 Mn
API Access

Skye Bioscience Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=SKYE&period=max&api_key=YOUR_API_KEY